110916 iran us israeliperspii
TRANSCRIPT
-
7/31/2019 110916 Iran US IsraeliPerspII
1/102
-
7/31/2019 110916 Iran US IsraeliPerspII
2/102
-
7/31/2019 110916 Iran US IsraeliPerspII
3/102
-
7/31/2019 110916 Iran US IsraeliPerspII
4/102
-
7/31/2019 110916 Iran US IsraeliPerspII
5/102
-
7/31/2019 110916 Iran US IsraeliPerspII
6/102
-
7/31/2019 110916 Iran US IsraeliPerspII
7/102
-
7/31/2019 110916 Iran US IsraeliPerspII
8/102
-
7/31/2019 110916 Iran US IsraeliPerspII
9/102
-
7/31/2019 110916 Iran US IsraeliPerspII
10/102
-
7/31/2019 110916 Iran US IsraeliPerspII
11/102
-
7/31/2019 110916 Iran US IsraeliPerspII
12/102
-
7/31/2019 110916 Iran US IsraeliPerspII
13/102
-
7/31/2019 110916 Iran US IsraeliPerspII
14/102
-
7/31/2019 110916 Iran US IsraeliPerspII
15/102
-
7/31/2019 110916 Iran US IsraeliPerspII
16/102
-
7/31/2019 110916 Iran US IsraeliPerspII
17/102
-
7/31/2019 110916 Iran US IsraeliPerspII
18/102
-
7/31/2019 110916 Iran US IsraeliPerspII
19/102
-
7/31/2019 110916 Iran US IsraeliPerspII
20/102
-
7/31/2019 110916 Iran US IsraeliPerspII
21/102
-
7/31/2019 110916 Iran US IsraeliPerspII
22/102
-
7/31/2019 110916 Iran US IsraeliPerspII
23/102
-
7/31/2019 110916 Iran US IsraeliPerspII
24/102
-
7/31/2019 110916 Iran US IsraeliPerspII
25/102
-
7/31/2019 110916 Iran US IsraeliPerspII
26/102
-
7/31/2019 110916 Iran US IsraeliPerspII
27/102
-
7/31/2019 110916 Iran US IsraeliPerspII
28/102
-
7/31/2019 110916 Iran US IsraeliPerspII
29/102
-
7/31/2019 110916 Iran US IsraeliPerspII
30/102
-
7/31/2019 110916 Iran US IsraeliPerspII
31/102
-
7/31/2019 110916 Iran US IsraeliPerspII
32/102
-
7/31/2019 110916 Iran US IsraeliPerspII
33/102
-
7/31/2019 110916 Iran US IsraeliPerspII
34/102
-
7/31/2019 110916 Iran US IsraeliPerspII
35/102
-
7/31/2019 110916 Iran US IsraeliPerspII
36/102
-
7/31/2019 110916 Iran US IsraeliPerspII
37/102
-
7/31/2019 110916 Iran US IsraeliPerspII
38/102
-
7/31/2019 110916 Iran US IsraeliPerspII
39/102
-
7/31/2019 110916 Iran US IsraeliPerspII
40/102
-
7/31/2019 110916 Iran US IsraeliPerspII
41/102
-
7/31/2019 110916 Iran US IsraeliPerspII
42/102
-
7/31/2019 110916 Iran US IsraeliPerspII
43/102
-
7/31/2019 110916 Iran US IsraeliPerspII
44/102
-
7/31/2019 110916 Iran US IsraeliPerspII
45/102
-
7/31/2019 110916 Iran US IsraeliPerspII
46/102
-
7/31/2019 110916 Iran US IsraeliPerspII
47/102
-
7/31/2019 110916 Iran US IsraeliPerspII
48/102
-
7/31/2019 110916 Iran US IsraeliPerspII
49/102
-
7/31/2019 110916 Iran US IsraeliPerspII
50/102
-
7/31/2019 110916 Iran US IsraeliPerspII
51/102
-
7/31/2019 110916 Iran US IsraeliPerspII
52/102
-
7/31/2019 110916 Iran US IsraeliPerspII
53/102
-
7/31/2019 110916 Iran US IsraeliPerspII
54/102
-
7/31/2019 110916 Iran US IsraeliPerspII
55/102
-
7/31/2019 110916 Iran US IsraeliPerspII
56/102
-
7/31/2019 110916 Iran US IsraeliPerspII
57/102
-
7/31/2019 110916 Iran US IsraeliPerspII
58/102
-
7/31/2019 110916 Iran US IsraeliPerspII
59/102
-
7/31/2019 110916 Iran US IsraeliPerspII
60/102
-
7/31/2019 110916 Iran US IsraeliPerspII
61/102
-
7/31/2019 110916 Iran US IsraeliPerspII
62/102
-
7/31/2019 110916 Iran US IsraeliPerspII
63/102
-
7/31/2019 110916 Iran US IsraeliPerspII
64/102
-
7/31/2019 110916 Iran US IsraeliPerspII
65/102
-
7/31/2019 110916 Iran US IsraeliPerspII
66/102
-
7/31/2019 110916 Iran US IsraeliPerspII
67/102
-
7/31/2019 110916 Iran US IsraeliPerspII
68/102
-
7/31/2019 110916 Iran US IsraeliPerspII
69/102
-
7/31/2019 110916 Iran US IsraeliPerspII
70/102
-
7/31/2019 110916 Iran US IsraeliPerspII
71/102
-
7/31/2019 110916 Iran US IsraeliPerspII
72/102
-
7/31/2019 110916 Iran US IsraeliPerspII
73/102
-
7/31/2019 110916 Iran US IsraeliPerspII
74/102
-
7/31/2019 110916 Iran US IsraeliPerspII
75/102
-
7/31/2019 110916 Iran US IsraeliPerspII
76/102
-
7/31/2019 110916 Iran US IsraeliPerspII
77/102
-
7/31/2019 110916 Iran US IsraeliPerspII
78/102
-
7/31/2019 110916 Iran US IsraeliPerspII
79/102
-
7/31/2019 110916 Iran US IsraeliPerspII
80/102
-
7/31/2019 110916 Iran US IsraeliPerspII
81/102
-
7/31/2019 110916 Iran US IsraeliPerspII
82/102
-
7/31/2019 110916 Iran US IsraeliPerspII
83/102
-
7/31/2019 110916 Iran US IsraeliPerspII
84/102
-
7/31/2019 110916 Iran US IsraeliPerspII
85/102
-
7/31/2019 110916 Iran US IsraeliPerspII
86/102
-
7/31/2019 110916 Iran US IsraeliPerspII
87/102
-
7/31/2019 110916 Iran US IsraeliPerspII
88/102
-
7/31/2019 110916 Iran US IsraeliPerspII
89/102
-
7/31/2019 110916 Iran US IsraeliPerspII
90/102
-
7/31/2019 110916 Iran US IsraeliPerspII
91/102
-
7/31/2019 110916 Iran US IsraeliPerspII
92/102
-
7/31/2019 110916 Iran US IsraeliPerspII
93/102
-
7/31/2019 110916 Iran US IsraeliPerspII
94/102
-
7/31/2019 110916 Iran US IsraeliPerspII
95/102
Chemical & Biological Options
-
7/31/2019 110916 Iran US IsraeliPerspII
96/102
Q 50 for Some Types of BW -
-
7/31/2019 110916 Iran US IsraeliPerspII
97/102
Open-Air Deployment Plague (liquid): 3.5-4.5 liter/sq.km Tularemia (dry): 3.0-4.0 kg/sq.km Anthrax (dry, old version): 15-20 kg/sq.km Anthrax (dry, new version): 4.5-5.0 kg/sq.km
Anthrax (liquid): 5.0-5.5 liter/sq.km Brucellosis (dry): 3.5-4.5 kg/sq.km Glanders/Melioidosis (liquid): 4.5-5.5 liter/sq.km
Smallpox (liquid): 3.5-4.0 liter/sq.km Marburg (dry): less than 1.0 kg/sq.km
New Types of Biological Weapons
-
7/31/2019 110916 Iran US IsraeliPerspII
98/102
Binary biological weapons that use two safe to handle elements that can be assembled before use.This could be a virus and helper virus like Hepatitis D or a bacterial virulence plasmid like E. coli,plague, Anthrax, and dysentery.
Designer genes and life forms, which could include synthetic genes and gene networks, syntheticviruses, and synthetic organisms. These weapons include DNA shuffling, synthetic forms of the flu which killed more people in 1918 than died in all of World War I and which still kills about 30,000Americans a year and synthetic microorganisms.
"Gene therapy" weapons that use transforming viruses or similar DNA vectors carrying Trojanhorse genes (retrovirus, adenovirus, poxvirus, HSV-1). Such weapons can produce single individual(somatic cell) or inheritable (germline) changes. It can also remove immunities and wound healingcapabilities.
Stealth viruses can be transforming or conditionally inducible. They exploit the fact that humansnormally carry a substantial viral load, and examples are the herpes virus, cytomegalovirus,Epstein-Barr, and SV40 contamination which are normally dormant or limited in infect but can betransformed into far more lethal diseases. They can be introduced over years and then used toblackmail a population.
Host-swapping diseases: Viral parasites normally have narrow host ranges and develop anevolutionary equilibrium with their hosts. Disruption of this equilibrium normally produces noresults, but it can be extremely lethal. Natural examples include AIDS, Hantavirus, Marburg, andEbola. Tailoring the disruption for attack purposes can produce weapons that are extremely lethaland for which there is no treatment. A tailored disease like AIDS could combine serious initiallethality with crippling long-term effects lasting decades.
Designer diseases involve using molecular biology to create the disease first and then constructing apathogen to produce it. It could eliminate immunity, target normally dormant genes, or instructcells to commit suicide. Apoptosis is programmed cell death, and specific apoptosis can be used tokill any mix of cells.
-
7/31/2019 110916 Iran US IsraeliPerspII
99/102
Soviet RBK-type Cluster Bomb for CBR Weapons
Source: Ken Alibeck
-
7/31/2019 110916 Iran US IsraeliPerspII
100/102
-
7/31/2019 110916 Iran US IsraeliPerspII
101/102
State Actor Covert Bioterrorism, Suitcase Nuclear
Bypasses defenses.
Plausible deniability?
Exploits special vulnerability of one bomb states.
Psychological and political impacts as important as direct killing
effects. False flag and proxy options clear.
Buying time may limit risk of retaliation.
Allows to exploit slow kill nature of biological strikes. Achieve line source effects
Covert forces in place can restrike or escalate.
Target potentially faces major weakening of conventionalcapabilities without ability to counter-escalate.
Possible Terrorist/Covert/Irregular
-
7/31/2019 110916 Iran US IsraeliPerspII
102/102
Deployment of Biological Weapons Use of infected vectors (mosquitoes, fleas, lice, etc.)
Contamination of food and water supplies
Contamination of various articles (letters, books, surfaces,etc.)
Use of different aerosolizing devices and approaches tocontaminate inner spaces of various buildings (line andpoint sources)
Use of different aerosolizing devices and approaches foropen-air dissemination (line and point sources)
Inner- and outer-space explosive dissemination includingsuicide bombers
T i t/S b t g th d f i f ti g d li t k